Azitra (AZTR) Shares Outstanding (2022 - 2026)

Azitra (AZTR) posted Shares Outstanding (Entity) of $568240.0 for Q4 2024, down 34.91% on a QoQ basis from $873025.0 in Q3 2024, and up 1539.8% year-over-year from $34653.0 in Q1 2024.

Azitra (AZTR) Shares Outstanding (2022 - 2026) Analysis & Trends

Azitra's Shares Outstanding (Entity) history runs 2 years deep, the most recent figure standing at $568240.0 for Q4 2024.

  • Quarterly Shares Outstanding (Entity) rose 1539.8% year-over-year to $568240.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $568240.0 (up 1539.8% YoY) and the FY2024 annual result came in at $568240.0, up 1539.8% from the prior year.
  • Shares Outstanding (Entity) was $568240.0 for Q4 2024 at Azitra, down from $873025.0 in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $873025.0 in Q3 2024 and bottomed at $10747.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Nanobiotix 1,785.82 Bn 1,785.76 Bn - 47.82 Bn
2 Akari Therapeutics 979.03 Bn 979.03 Bn - 118.76 Bn
3 BeOne Medicines 472.98 Bn 468.19 Bn 1.35 Bn 1.44 Bn
4 Vertex Pharmaceuticals 123.73 Bn 116.48 Bn 2.59 Bn 254.10 Mn
5 Regeneron Pharmaceuticals 71.59 Bn 62.84 Bn 3.31 Bn 104.00 Mn
6 Belite Bio 62.00 Bn 62.00 Bn - 400.00 Mn
7 Argenx Se 54.67 Bn 49.49 Bn 1.41 Bn 62.19 Mn
8 Alnylam Pharmaceuticals 37.96 Bn 34.95 Bn 959.66 Mn 132.89 Mn
9 Revolution Medicines 36.08 Bn 36.08 Bn - 198.10 Mn
10 Azitra 2.07 Mn 2.07 Mn - 15.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.52 Mn
Dec 31, 2025 4.87 Mn
Sep 30, 2025 4.12 Mn
Jun 30, 2025 2.44 Mn
Mar 31, 2025 1.98 Mn
Dec 31, 2024 568,240.00
Sep 30, 2024 873,025.00
Jun 30, 2024 144,166.00
Mar 31, 2024 101,003.00
Dec 31, 2023 34,653.00
Sep 30, 2023 60,543.00
Jun 30, 2023 10,747.00
Mar 31, 2023 5,282.00
Dec 31, 2022 5,282.00
Sep 30, 2022 5,282.00
Jun 30, 2022 5,282.00